Calamos Wealth Management LLC Bristol Myers Squibb CO Transaction History

Calamos Wealth Management LLC

$1.93 Billion
Q4 2024

A detailed history of Calamos Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Calamos Wealth Management LLC holds 11,123 shares of BMY stock, worth $632,342. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,123

Previous 10,853 2.49%

Holding current value

$632,342

Previous $561,000 12.12%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$51.92 - $59.94 $14,018 - $16,183	270 Added 2.49%	11,123 $629,000
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $234,668 - $306,204	-5,917 Reduced 35.28%	10,853 $561,000
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $46,247 - $60,885	1,149 Added 7.36%	16,770 $696,000
Q1 2024 May 08, 2024	SELL	$47.98 - $54.4 $10,603 - $12,022	-221 Reduced 1.4%	15,621 $847,000
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $135,937 - $162,211	-2,804 Reduced 15.04%	15,842 $812,000
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $6.03 Million - $6.74 Million	-104,165 Reduced 84.82%	18,646 $1.08 Million
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $2.05 Million - $2.28 Million	-32,212 Reduced 20.78%	122,811 $7.85 Million
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $1.4 Million - $1.59 Million	-21,344 Reduced 12.1%	155,023 $10.7 Million
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $77,245 - $91,469	1,128 Added 0.64%	176,367 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $733 - $433,454	5,641 Added 3.33%	175,239 $12.5 Million
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $713,564 - $785,883	9,826 Added 6.15%	169,598 $13.1 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $3.02 Million - $3.62 Million	49,156 Added 44.44%	159,772 $11.7 Million
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $91,063 - $106,158	1,698 Added 1.56%	110,616 $6.9 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $2.37 Million - $2.78 Million	40,106 Added 58.28%	108,918 $6.45 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $97,570 - $106,253	-1,576 Reduced 2.24%	68,812 $4.6 Million
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $103,904 - $116,861	1,751 Added 2.55%	70,388 $4.44 Million
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $524,914 - $594,824	9,091 Added 15.27%	68,637 $4.26 Million
Q3 2020 Oct 26, 2020	BUY	$57.43 - $63.64 $135,534 - $150,190	2,360 Added 4.13%	59,546 $3.59 Million
Q2 2020 Jul 27, 2020	BUY	$54.82 - $64.09 $68,525 - $80,112	1,250 Added 2.23%	57,186 $3.36 Million
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $2.6 Million - $3.77 Million	55,936 New	55,936 $3.12 Million
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $469,625 - $585,336	-9,294 Closed	0 $0
Q1 2018 Apr 13, 2018	BUY	$59.92 - $68.98 $556,896 - $641,100	9,294 New	9,294 $588,000

Others Institutions Holding BMY

# of Institutions

2,639

Shares Held

1.46B

Call Options Held

31.5M

Put Options Held

34.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Account

Calamos Wealth Management LLC Bristol Myers Squibb CO Transaction History